Klein Elizabeth G, Berman Micah, Hemmerich Natalie, Carlson Cristen, Htut SuSandi, Slater Michael
Elizabeth G. Klein, Associate Professor, The Ohio State University College of Public Health, Columbus, OH. Micah Berman, Assistant Professor, The Ohio State University College of Public Health and Moritz College of Law, Columbus, OH. Natalie Hemmerich, Postdoctoral Fellow, Center of Excellence in Regulatory Tobacco Science, The Ohio State University College of Public Health, Columbus, OH. Cristen Carlson, MPH, Hamilton County Public Health, Cincinnati, OH. SuSandi Htut, Research Assistant, Center of Excellence in Regulatory Tobacco Science, The Ohio State University College of Public Health, Columbus, OH. Michael Slater, Professor, School of Communication, The Ohio State University College of Arts & Sciences, Columbus, OH.
Tob Regul Sci. 2016 Jul;2(3):252-262. doi: 10.18001/TRS.2.3.5. Epub 2016 Jul 1.
Electronic nicotine delivery systems (ENDS), or e-cigarettes, are heavily marketed online. The purpose of our study was to perform a systematic identification and evaluation of claims made within ENDS retailer and manufacturer websites, and the legal status of such claims.
We employed a systematic search protocol with popular search engines using 6 terms: (1) e-cigarettes; (2) e-cigs; (3) e-juice; (4) e-liquid; (5) e-hookah; and (6) vape pen. We analyzed English-language websites where ENDS are sold for implicit and explicit health-related claims. A legal analysis determined whether such claims are permissible under the US Food and Drug Administration's regulations.
The vast majority of ENDS manufacturer (N = 78) and retailer (N = 32) websites made at least one health-related claim (77% and 65%, respectively). Modified risk claims and secondhand smoke-related claims were most prevalent, with an average of 2 claims per site.
Health-related claims are plentiful within ENDS manufacturer and retailer websites. Results demonstrate that these sites focus on potential benefits while minimizing or eliminating information about possible harmful effects of ENDS. These claims are subject to the current regulatory authority by the FDA, and pose a risk of misinforming consumers.
电子尼古丁传送系统(ENDS),即电子烟,在网上大量销售。我们研究的目的是对ENDS零售商和制造商网站上的声明以及这些声明的法律地位进行系统识别和评估。
我们使用流行的搜索引擎,采用系统搜索协议,使用6个术语:(1)电子烟;(2)电子香烟;(3)电子烟液;(4)电子液体;(5)电子水烟;(6)电子烟笔。我们分析了销售ENDS的英文网站上与健康相关的隐含和明确声明。法律分析确定了这些声明在美国食品药品监督管理局的规定下是否允许。
绝大多数ENDS制造商(N = 78)和零售商(N = 32)网站至少提出了一项与健康相关的声明(分别为77%和65%)。改良风险声明和与二手烟相关的声明最为普遍,每个网站平均有2项声明。
ENDS制造商和零售商网站上与健康相关的声明很多。结果表明,这些网站关注潜在益处,同时尽量减少或消除有关ENDS可能有害影响的信息。这些声明受美国食品药品监督管理局现行监管机构监管,有误导消费者的风险。